Calciphylaxis in the absence of end-stage renal disease

Endocrine Practice

Volumn 12, Issue 4, 2006, Pages 406-410

  Couto, Francesca M ^a   Chen, Herbert ^b   Blank, Robert D ^a   Drezner, Marc K ^a  

^a Department of Medicine   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; PREDNISONE; VITAMIN D;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; FEMALE; HUMAN; HYPOCALCEMIA; HYPOPHOSPHATEMIA; INTRACTABLE PAIN; KIDNEY FAILURE; KIDNEY FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; QUALITY OF LIFE; SECONDARY HYPERPARATHYROIDISM; SKIN ULCER; THYMECTOMY; VITAMIN D DEFICIENCY; WOUND INFECTION; BLOOD; CHRONIC KIDNEY FAILURE; METABOLIC AND NUTRITIONAL SKIN DISEASE; MIDDLE AGED; PATHOLOGY; WOUND HEALING;

CALCIPHYLAXIS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; SKIN DISEASES, METABOLIC; WOUND HEALING;

EID: 33750130005     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.4.406     Document Type: Article

References (27)

1. Winkelmann RK, Keating FR Jr. Cutaneous vascular calcification, gangrene and hyperparathyroidism. Br J Dermatol. 1970;83:263-268.
2. Pollock B, Cunliffe WJ, Merchant WJ. Calciphylaxis in the absence of renal failure. Clin Exp Dermatol. 2002;25:389-392.
3. Barri YM, Graves GS, Knochel JP. Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis. 1997;29:773-776.
4. Goyal S, Huhn K, Provost TT. Calciphylaxis without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy. Br J Dermatol. 2000; 143:1087-1090.
5. Mastruserio DN, Nguyen EQ, Nielsen T, Hessel A, Pellegrini AE. Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol. 1999;41(2 Pt 2):295-298.
6. Fader DJ, Kang S. Calciphylaxis without renal failure (letter]. Arch Dermatol. 1996;132:837-838.
7. Korkmaz C, Dundar E, Zubaroglu I. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol. 2002;21:66-69.
8. Riegert-Johnson DL, Kaur JS, Pfeifer EA. Calciphytaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin Proc. 2001;76:749-752.
9. Randall DP, Fisher MA, Thomas C. Rhabdomyolysis as the presenting manifestation of calciphylaxis. Muscle Nerve. 2000;23:289-293.
10. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004;286:E686-E696.
11. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature. 1997;386:78-81.
12. Schäfer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357-366.
13. Hafner J, Keusch G, Wahl C, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic failure and benefit from parathyroidectomy. J Am Acad Dermatol. 1995;33:954-962.
14. Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism [with discussion]. Surgery. 2001;130:645-651.
15. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15:172-186.
16. Selye H. Calciphylaxis. Chicago, IL: University of Chicago Press, 1962.
17. Price PA, Omid N, Than TN, Williamson MK. The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption. Calcif Tissue Int. 2002;71:356-363.
18. Don BR, Chin AI. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol. 2003;59:463-470.
19. Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001;60:324-332.
20. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002;61:2210-2217.
21. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL. A case control study of proximal calciphylaxis. Am J Kidney Dis. 1998;32:376-383.
22. Voskuyl AE, Hazes JM, Zwinderman AH, et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis. 2003;62:407-413.
23. Mehta RL, Scott G, Sloand JA, Francis CW. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Am J Med. 1990;88:252-257.
24. Perez-Mijares R, Guzman-Zamudio JL, Payan-Lopez J, Rodriguez-Fernandez A, Gomez-Fernandez P, Almaraz-Jimenez M. Calciphylaxis in a haemodialysis patient: functional protein S deficiency? Nephrol Dial Transplant. 1996;11:1856-1859.
25. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89:3152-3157.
26. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol. 2002; 15:676-680.
27. Kang AS, McCarthy JT, Rowland C, Farley DR, van Heerden JA. Is calciphylaxis best treated surgically or medically [with discussion]? Surgery. 2000;128:967-972.